17 research outputs found
Outcome of osteoarthritis and arthroplasty from patient perspective to molecular profiling.
With increasing life
expectancy, the incidence and burden of osteoarthritis on society increases.
Currently, no treatment for end-stage symptomatic osteoarthritis is available
and when symptoms become too severe arthroplasty surgery will be performed,
replacing the affected joint with a prosthesis. Although replacement surgery of
the hip or knee is safe and commonly performed, up to 20% of the patients are
unsatisfied with the outcome. The exact reasons for this dissatisfaction are
unknown but may vary from the type of surgical procedure itself, expectancy of
the outcome surgery to the patient’s preoperative state of overall metabolic
health.
We aimed to evaluate some of these aspects related to outcome, from patient
perspectives to molecular profiling (e.g. metabolic health). Characteristics of
different nature were included: material of prosthesis, physical activity,
questionnaires, clinical measures and metabolomics. This holistic approach
enables the assessment of more patient specific targets such as advices on
treatment modalities. Ultimately, selection of patients, both from a patient’s
as well as orthopaedic surgeon’s perspective, will be optimised for the best
intervention for the patient. Since osteoarthritis is the major driver for
performing arthroplasty, the conclusion of this thesis will spark future
studies into OA and its overall effect on disability.LUMC / Geneeskund
Frailty in end-stage hip or knee osteoarthritis: validation of the Groningen Frailty Indicator (GFI) questionnaire
Molecular Epidemiolog
Serum fatty acid chain length associates with prevalent symptomatic end-stage osteoarthritis, independent of BMI
Higher body mass index (BMI) is associated with osteoarthritis (OA) in both weight-bearing and non-weight-bearing joints, suggesting a link between OA and poor metabolic health beyond mechanical loading. This risk may be influenced by systemic factors accompanying BMI. Fluctuations in concentrations of metabolites may mark or even contribute to development of OA. This study explores the association of metabolites with radiographic knee/hip OA prevalence and progression. A 1H-NMR-metabolomics assay was performed on plasma samples of 1564 cases for prevalent OA and 2,125 controls collected from the Rotterdam Study, CHECK, GARP/NORREF and LUMC-arthroplasty cohorts. OA prevalence and 5 to 10 year progression was assessed by means of Kellgren-Lawrence (KL) score and the OARSI-atlas. End-stage knee/hip OA (TJA) was defined as indication for arthroplasty surgery. Controls did not have OA at baseline or follow-up. Principal component analysis of 227 metabolites demonstrated 23 factors, of which 19 remained interpretable after quality-control. Associations of factor scores with OA definitions were investigated with logistic regression. Fatty acids chain length (FALen), which was included in two factors which associated with TJA, was individually associated with both overall OA as well as TJA. Increased Fatty Acid chain Length is associated with OA
Heritability estimates for 361 blood metabolites across 40 genome-wide association studies
Metabolomics examines the small molecules involved in cellular metabolism. Approximately 50% of total phenotypic differences in metabolite levels is due to genetic variance, but heritability estimates differ across metabolite classes. We perform a review of all genome-wide association and (exome-) sequencing studies published between November 2008 and October 2018, and identify >800 class-specific metabolite loci associated with metabolite levels. In a twin-family cohort (N = 5117), these metabolite loci are leveraged to simultaneously estimate total heritability (h2 total), and the proportion of heritability captured by known metabolite loci (h2 Metabolite-hits) for 309 lipids and
Outcome of osteoarthritis and arthroplasty from patient perspective to molecular profiling.
With increasing life
expectancy, the incidence and burden of osteoarthritis on society increases.
Currently, no treatment for end-stage symptomatic osteoarthritis is available
and when symptoms become too severe arthroplasty surgery will be performed,
replacing the affected joint with a prosthesis. Although replacement surgery of
the hip or knee is safe and commonly performed, up to 20% of the patients are
unsatisfied with the outcome. The exact reasons for this dissatisfaction are
unknown but may vary from the type of surgical procedure itself, expectancy of
the outcome surgery to the patient’s preoperative state of overall metabolic
health.
We aimed to evaluate some of these aspects related to outcome, from patient
perspectives to molecular profiling (e.g. metabolic health). Characteristics of
different nature were included: material of prosthesis, physical activity,
questionnaires, clinical measures and metabolomics. This holistic approach
enables the assessment of more patient specific targets such as advices on
treatment modalities. Ultimately, selection of patients, both from a patient’s
as well as orthopaedic surgeon’s perspective, will be optimised for the best
intervention for the patient. Since osteoarthritis is the major driver for
performing arthroplasty, the conclusion of this thesis will spark future
studies into OA and its overall effect on disability.</p
Frailty Questionnaire Is Not a Strong Prognostic Factor for Functional Outcomes in Hip or Knee Arthroplasty Patients
Orthopaedics, Trauma Surgery and Rehabilitatio
Physical activity in patients with systemic sclerosis
Development and application of statistical models for medical scientific researc
Association of handgrip strength with patient-reported outcome measures after total hip and knee arthroplasty
About 33% patients with osteoarthritis undergoing total hip/knee arthroplasty are not satisfied with the outcome, warranting the need to improve patient selection. Handgrip strength (HGS) has been suggested as a proxy for overall muscle strength and may be associated with post-arthroplasty function. This study aims to assess the association of pre-operative HGS with change in hip/knee function and quality of life in patients with arthroplasty. 226 hip (THA) and 246 knee (TKA) arthroplasty patients were included in this prospective cohort study. Pre-operative HGS was assessed by means of a dynamometer and the HOOS/KOOS and SF-36 questionnaires were collected before arthroplasty and 1 year thereafter. The association of HGS with score change on each sub-domain of the included questionnaires was assessed by linear regression models, adjusting for sex, body mass index and baseline score. Mean pre-operative HGS was 26 kg for patients undergoing THA and 24 kg for those undergoing TKA. HGS was positively associated with an increased improvement score on "function in sport and recreation"-domain in hip (beta = 0.68, P = 0.005) and knee (beta = 0.52, P = 0.049) and "symptoms"-domain in hip (beta = 0.56, P = 0.001). For patients with THA, HGS was associated with the "quality of life" domain (beta = 0.33, P = 0.033). In patients with TKA, HGS was associated with the physical component score (beta = 0.31, P = 0.001). All statistically significant effects were positive, indicating that with greater pre-operative HGS, an increased gain in 1-year post-surgery score was observed. HGS can be used as a tool to inform patients with OA who are future candidates for a prosthesis about the possible improvements of certain aspects of life after arthroplasty.Development and application of statistical models for medical scientific researc
Patients who underwent total hip or knee arthroplasty are more physically active than the general Dutch population
Development and application of statistical models for medical scientific researc
MoM total hip replacements in Europe: a NORE report
The purpose of this paper is to determine the prevalence of metal-on-metal (MoM) total hip replacement (THR) in European registries, to assess the incidence of revision surgery and to describe the national follow-up guidelines for patients with MoM THR including resurfacings.Eleven registries of the Network of Orthopaedic Registries of Europe (NORE) participated totalling 54 434 resurfacings and 58 498 large stemmed MoM THRs.The resurfacings and stemmed large head MoM had higher pooled revision rates at five years than the standard total hip arthroplasties (THA): 6.0%, 95% confidence interval (CI) 5.3 to 6.8 for resurfacings; 6.9%, 95% CI 4.4 to 9.4 for stemmed large head MoM; and 3.0%, 95% CI 2.5 to 3.6 for conventional THA.The resurfacings and stemmed large head MoM had higher pooled revision rates at ten years than the standard THAs: 12.1%, 95% CI 11.0 to 13.3 for resurfacings; 15.5%, 95% CI 9.0 to 22 for stemmed large head MoM; and 5.1%, 95% CI 3.8 to 6.4 for conventional THA.Although every national registry reports slightly different protocols for follow-up, these mostly consist of annual assessments of cobalt and chromium levels in blood and MRI (MARS) imaging.Orthopaedics, Trauma Surgery and Rehabilitatio